Fund HoldingsCAXTON CORP

Total Portfolio Value
$18.52M
Total Bought
$1.44M
Total Sold
$11.22M
Net Transaction
-$9.78M
Filing Period:
Securities
SharesValue ($K)
Q3 2023
Q4 2023
Change
Q3 2023
Q4 2023
Weight (%)
Change
XERIS BIOPHARMA HOLDINGS INC5,641,9205,641,920010,49413,25971.57%+2,765
SPDR S&P 500 ETF TR(SPY)01,322+1,32206283.39%+628
BERKSHIRE HATHAWAY INC DEL01,035+1,03503691.99%+369
ABIVAX SA(ABVX)016,743+16,74301790.97%+179
LEXEO THERAPEUTICS INC010,319+10,31901380.75%+138
HARPOON THERAPEUTICS INC013,176+13,17601290.70%+129
ELEVATION ONCOLOGY INC21,8130-21,813140-14
ALLAKOS INC49,32924,710-24,619112670.36%-45
APOGEE THERAPEUTICS INC(APGE)12,4727,353-5,1192662051.11%-60
COMPASS THERAPEUTICS INC86,77343,465-43,308171680.37%-103
ACLARIS THERAPEUTICS INC(ACRS)19,4730-19,4731330-133
MOLECULAR TEMPLATES INC136,866136,86608655112.76%-354
REZOLUTE INC1,318,9671,318,96701,7411,3097.07%-432
SAVARA INC(SVRA)3,313,602353,441-2,960,16112,5251,6618.97%-10,864
Page 1 of 1